VEOR SURGERY
SOUTH TERRACE, CAMBORNE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 44 | 50 | 88.0% | |
| HF 4 | 2011 | 44 | 51 | 86.3% | |
| HF 4 | 2012 | 39 | 43 | 90.7% | |
| HF 4 | 2013 | 42 | 45 | 93.3% | |
| HF004 | 2014 | 34 | 39 | 87.2% | |
| HF004 | 2015 | 32 | 37 | 86.5% | |
| HF004 | 2016 | 26 | 30 | 86.7% | |
| HF004 | 2017 | 26 | 32 | 81.2% | |
| HF004 | 2018 | 27 | 28 | 96.4% | |
| HF004 | 2019 | 35 | 39 | 89.7% | |
| HF004 | 2020 | 35 | 39 | 89.7% | |
| HF006 | 2021 | 47 | 54 | 87.0% | |
| HF006 | 2022 | 44 | 51 | 86.3% | |
| HF006 | 2023 | 46 | 55 | 83.6% |
